These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37654670)

  • 21. The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation.
    Routy B; Letendre C; Enot D; Chénard-Poirier M; Mehraj V; Séguin NC; Guenda K; Gagnon K; Woerther PL; Ghez D; Lachance S
    Oncoimmunology; 2017; 6(1):e1258506. PubMed ID: 28197380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD.
    Liu Y; Zhao Y; Qi J; Ma X; Qi X; Wu D; Xu Y
    Exp Hematol Oncol; 2022 Nov; 11(1):96. PubMed ID: 36352455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.
    Bonig H; Kuçi Z; Kuçi S; Bakhtiar S; Basu O; Bug G; Dennis M; Greil J; Barta A; Kállay KM; Lang P; Lucchini G; Pol R; Schulz A; Sykora KW; Teichert von Luettichau I; Herter-Sprie G; Ashab Uddin M; Jenkin P; Alsultan A; Buechner J; Stein J; Kelemen A; Jarisch A; Soerensen J; Salzmann-Manrique E; Hutter M; Schäfer R; Seifried E; Paneesha S; Novitzky-Basso I; Gefen A; Nevo N; Beutel G; Schlegel PG; Klingebiel T; Bader P
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruxolitinib in children with steroid-refractory acute graft-versus-host disease: A retrospective multicenter study of the pediatric group of SFGM-TC.
    Laisne L; Neven B; Dalle JH; Galambrun C; Esvan M; Renard C; Rialland F; Sirvent A; Gandemer V;
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28233. PubMed ID: 32614145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α
    Magenau JM; Goldstein SC; Peltier D; Soiffer RJ; Braun T; Pawarode A; Riwes MM; Kennel M; Antin JH; Cutler CS; Ho VT; Alyea EP; Parkin BL; Yanik GA; Choi SW; Lewis EC; Dinarello CA; Koreth J; Reddy P
    Blood; 2018 Mar; 131(12):1372-1379. PubMed ID: 29437593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
    Youngster I; Eshel A; Geva M; Danylesko I; Henig I; Zuckerman T; Fried S; Yerushalmi R; Shem-Tov N; Fein JA; Bomze D; Shimoni A; Koren O; Shouval R; Nagler A
    Bone Marrow Transplant; 2024 Mar; 59(3):409-416. PubMed ID: 38212672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons.
    Tremblay G; Tomaras D; Strati E; Forsythe A
    J Health Econ Outcomes Res; 2021 Feb; 8(1):10-17. PubMed ID: 33768123
    [No Abstract]   [Full Text] [Related]  

  • 28. An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.
    Bueno F; Albert E; Giménez E; Piñana JL; Pérez A; Dolores Gómez M; Hernández-Boluda JC; Gonzalez-Barberá EM; Montoro J; Buesa J; Guerreiro M; Balaguer-Roselló A; Hernani R; Sanz J; Solano C; Navarro D
    J Med Virol; 2021 Aug; 93(8):4773-4779. PubMed ID: 33605457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study.
    Tan Y; Xiao H; Wu D; Luo Y; Lan J; Liu Q; Yu K; Shi J; He J; Zheng W; Lai X; Zhu Y; Du K; Ye Y; Zhao Y; Zheng G; Hu Y; Han X; Zheng Y; Wei G; Cai Z; Huang H
    Oncoimmunology; 2017; 6(3):e1277307. PubMed ID: 28405499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-CD(25) monoclonal antibody as a salvage therapy for steroid-refractory acute graft-versus-host disease in 80 patients receiving allogeneic hematopoietic stem cell transplantation].
    Tao T; Xue SL; Chen F; Xu Y; Ma X; Miao M; Tang XW; Wu DP
    Zhonghua Nei Ke Za Zhi; 2018 May; 57(5):324-329. PubMed ID: 29747286
    [No Abstract]   [Full Text] [Related]  

  • 31. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease.
    Schroeder MA; Khoury HJ; Jagasia M; Ali H; Schiller GJ; Staser K; Choi J; Gehrs L; Arbushites MC; Yan Y; Langmuir P; Srinivas N; Pratta M; Perales MA; Chen YB; Meyers G; DiPersio JF
    Blood Adv; 2020 Apr; 4(8):1656-1669. PubMed ID: 32324888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.
    Kebriaei P; Hayes J; Daly A; Uberti J; Marks DI; Soiffer R; Waller EK; Burke E; Skerrett D; Shpall E; Martin PJ
    Biol Blood Marrow Transplant; 2020 May; 26(5):835-844. PubMed ID: 31505228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.
    Oarbeascoa G; Lozano ML; Guerra LM; Amunarriz C; Saavedra CA; Garcia-Gala JM; Viejo A; Revilla N; Acosta Fleitas C; Arroyo JL; Martinez Revuelta E; Galego A; Hernandez-Maraver D; Kwon M; Diez-Martin JL; Pascual C;
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):651-658. PubMed ID: 31917270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation.
    Minculescu L; Kornblit BT; Friis LS; Schiødt I; Petersen SL; Andersen NS; Sengeloev H
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):600-607. PubMed ID: 29074374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease.
    Mehta RS; Saliba RM; Jan A; Shigle TL; Wang E; Nieto Y; Ciurea SO; Oran B; Im J; Olson A; Marin D; Qazilbash M; Khouri I; Rondon G; Anderlini P; Rezvani K; Popat U; Kebriaei P; Shpall E; Champlin R; Alousi A
    Transplant Cell Ther; 2021 Mar; 27(3):272.e1-272.e5. PubMed ID: 33781539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of intra-arterial steroid administration for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease.
    Bérczi V; Tóth A; Tatai G; Fábián J; Reményi P; Masszi T
    Clin Radiol; 2019 Apr; 74(4):301-305. PubMed ID: 30691732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease.
    van Groningen LF; Liefferink AM; de Haan AF; Schaap NP; Donnelly JP; Blijlevens NM; van der Velden WJ
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):179-82. PubMed ID: 26386320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies.
    Bay JO; Dhédin N; Goerner M; Vannier JP; Marie-Cardine A; Stamatoullas A; Jouet JP; Yakoub-Agha I; Tabrizi R; Faucher C; Diez-Martin JL; Nunez G; Parody R; Milpied N; Espérou H; Garban F; Galambrun C; Kwiatkovski F; Darlavoix I; Zinaï A; Fischer A; Michallet M; Vernant JP
    Transplantation; 2005 Sep; 80(6):782-8. PubMed ID: 16210965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research advances on short-chain fatty acids in gastrointestinal acute graft-
    Song X; Lao J; Wang L; Liu S
    Ther Adv Hematol; 2024; 15():20406207241237602. PubMed ID: 38558826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.